Gentamicin-collagen sponge for infection prophylaxis in colorectal surgery

New England Journal of Medicine

Volumn 363, Issue 11, 2010, Pages 1038-1049

  Bennett Guerrero, Elliott ^a   Pappas, Theodore N ^a   Koltun, Walter A ^b   Fleshman, James W ^c   Lin, Min ^a   Garg, Jyotsna ^a   Mark, Daniel B ^a   Marcet, Jorge E ^d   Remzi, Feza H ^e   George, Virgilio V ^f   Newland, Kerstin ^a   Corey, G R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; COLLAGEN SPONGE; ERYTHROMYCIN; GENTAMICIN; METRONIDAZOLE; NEOMYCIN;

ADULT; ARTICLE; CLINICAL TRIAL; COLORECTAL SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SURGICAL INFECTION; SURGICAL TECHNIQUE;

EID: 77956548349     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1000837     Document Type: Article

References (23)

1. Greif R, Akça O, Horn EP, Kurz A, Sessler DI. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. N Engl J Med 2000;342:161-7. (Pubitemid 30051647)
2. Itani KM, Wilson SE, Awad SS, Jensen EH, Finn TS, Abramson MA. Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N Engl J Med 2006;355:2640-51.
3. Belda FJ, Aguilera L, Garcia de la Asuncion J, et al. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA 2005;294:2035-42.
4. Fleischmann E, Lenhardt R, Kurz A, et al. Nitrous oxide and risk of surgical wound infection: a randomised trial. Lancet 2005;366:1101-7.
5. Pryor KO, Fahey TJ III, Lien CA, Goldstein PA. Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA 2004;291:79-87. (Pubitemid 38040538)
6. Rutten HJ, Nijhuis PH. Prevention of wound infection in elective colorectal surgery by local application of a gentamicin-containing collagen sponge. Eur J Surg Suppl 1997;578:31-5.
7. Meyhoff CS, Wetterslev J, Jorgensen LN, et al. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA 2009;302:1543-50.
8. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999;20:725-30.
9. Walz JM, Paterson CA, Seligowski JM, Heard SO. Surgical site infection following bowel surgery: a retrospective analysis of 1446 patients. Arch Surg 2006;141:1014-8.
10. Smith RL, Bohl JK, McElearney ST, et al. Wound infection after elective colorectal resection. Ann Surg 2004;239:599-607.
11. Kurz A, Sessler DI, Lenhardt R. Peri-operative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. N Engl J Med 1996;334:1209-15.
12. Ruszczak Z, Friess W. Collagen as a carrier for on-site delivery of antibacterial drugs. Adv Drug Deliv Rev 2003;55:1679-98.
13. Guzmán Valdivia Gomez G, Guerrero TS, Lluck MC, Delgado FJ. Effectiveness of collagen-gentamicin implant for treatment of "dirty" abdominal wounds. World J Surg 1999;23:123-7.
14. Nowacki MP, Rutkowski A, Oledzki J, Chwalinski M. Prospective, randomized trial examining the role of gentamycin-containing collagen sponge in the reduction of postoperative morbidity in rectal cancer patients: early results and surprising outcome at 3-year follow-up. Int J Colorectal Dis 2005;20:114-20.
15. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004;38:1706-15.
16. Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med 1991;91:152S-157S.
17. Wilson AP, Gibbons C, Reeves BC, et al. Surgical wound infection as a performance indicator: agreement of common definitions of wound infection in 4773 patients. BMJ 2004;329:720.
18. Wilson AP, Weavill C, Burridge J, Kelsey MC. The use of the wound scoring method 'ASEPSIS' in postoperative wound surveillance. J Hosp Infect 1990;16:297-309.
19. Haley RW, Culver DH, Morgan WM, White JW, Emori TG, Hooton TM. Identifying patients at high risk of surgical wound infection: a simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol 1985;121:206-15.
20. Tam VH, Kabbara S, Vo G, Schilling AN, Coyle EA. Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006;50:2626-31.
21. Friberg O, Jones I, Sjöberg L, Söderquist B, Vikerfors T, Kallman J. Antibiotic concentrations in serum and wound fluid after local gentamicin or intravenous dicloxacillin prophylaxis in cardiac surgery. Scand J Infect Dis 2003;35:251-4.
22. Bellomo R, Warrillow SJ, Reade MC. Why we should be wary of single-center trials. Crit Care Med 2009;37:3114-9.
23. Glickman SW, McHutchison JG, Peterson ED, et al. Ethical and scientific implications of the globalization of clinical research. N Engl J Med 2009;360:816-23.